Elevance Health, Inc. (ELV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Core Perspective - The article discusses recent developments at Elevance, particularly concerning a letter from the Centers for Medicare & Medicaid Services (CMS) that raises concerns about historical risk adjustment data submission practices prior to April 2023 [1]. Group 1: CMS Sanctions and Concerns - CMS has outlined concerns related to historical risk adjustment data submission practices, indicating that this issue extends beyond mere data submission to a broader policy and payment dispute regarding retroactive corrections under the risk adjustment framework [1]. Group 2: Company Actions - The company has approached the situation with good faith and transparency, indicating a commitment to resolving the issues raised by CMS [2].